AAAAAA
Results:
1-11
|
Results: 11
Authors:
Nawrocki, S
Wysocki, PJ
Mackiewicz, A
Citation: S. Nawrocki et al., Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer, EXPERT OP B, 1(2), 2001, pp. 193-204
Authors:
Ozbek, S
Peters, M
Breuhahn, K
Mann, A
Blessing, M
Fischer, M
Schirmacher, P
Mackiewicz, A
Rose-John, S
Citation: S. Ozbek et al., The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells, ONCOGENE, 20(8), 2001, pp. 972-979
Authors:
Golab, J
Zagozdzon, R
Kaminski, R
Kozar, K
Gryska, K
Izycki, D
Mackiewicz, A
Stoklosa, T
Giermasz, A
Lasek, W
Jakobisiak, M
Citation: J. Golab et al., Potentiated antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo, LEUKEMIA, 15(4), 2001, pp. 613-620
Authors:
Kortylewski, M
Heinrich, PC
Kauffmann, ME
Bohm, M
Mackiewicz, A
Behrmann, I
Citation: M. Kortylewski et al., Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells, BIOCHEM J, 357, 2001, pp. 297-303
Authors:
Wysocka, M
Robertson, S
Riemann, H
Caamano, J
Hunter, C
Mackiewicz, A
Montaner, LJ
Trinchieri, G
Karp, CL
Citation: M. Wysocka et al., IL-12 suppression during experimental endotoxin tolerance: Dendritic cell loss and macrophage hyporesponsiveness, J IMMUNOL, 166(12), 2001, pp. 7504-7513
Authors:
Lasek, W
Mackiewicz, A
Czajka, A
Switaj, T
Golab, J
Wiznerowicz, M
Korczak-Kowalska, G
Bakowiec-Iskra, EZ
Gryska, K
Izycki, D
Jakobisiak, M
Citation: W. Lasek et al., Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice, CANC GENE T, 7(12), 2000, pp. 1581-1590
Authors:
Mackiewicz, A
Citation: A. Mackiewicz, Immunology in Poland, IMMUNOL TOD, 21(9), 2000, pp. 415-416
Authors:
Nawrocki, S
Murawa, P
Malicki, J
Kapcinska, M
Gryska, K
Izycki, D
Kaczmarek, A
Laciak, M
Czapczyk, A
Karczewska, A
Rose-John, S
Mackiewicz, A
Citation: S. Nawrocki et al., Genetically modified tumour vaccines (GMTV) in melanoma clinical trials, IMMUNOL LET, 74(1), 2000, pp. 81-86
Authors:
Karczewska, A
Nawrocki, S
Breborowicz, D
Filas, V
Mackiewicz, A
Citation: A. Karczewska et al., Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma, CANCER, 88(9), 2000, pp. 2061-2071
Authors:
Kortylewski, M
Heinrich, PC
Mackiewicz, A
Schniertshauer, U
Klingmuller, U
Nakajima, K
Hirano, T
Horn, F
Behrmann, I
Citation: M. Kortylewski et al., Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1, ONCOGENE, 18(25), 1999, pp. 3742-3753
Authors:
Nawrocki, S
Mackiewicz, A
Citation: S. Nawrocki et A. Mackiewicz, Genetically modified tumour vaccines - where we are today, CANC TR REV, 25(1), 1999, pp. 29-46
Risultati:
1-11
|